ОЗОН Фармацевтика (OZPH) EBITDA margin MSFO (year values) |
|||||||||
| 2021 | 2022 | 2023 | 2024 | 2025 | LTM ? | 5 years average | |||
| EBITDA margin, % | ? | 34.2% | 36.0% | 37.9% | 37.1% | 38.6% | 39.6% | ||
| Changes by years, y/y, % | +2pp | +2pp | -1pp | +1pp | +37% | ||||
ОЗОН Фармацевтика. EBITDA margin, %
ОЗОН Фармацевтика. EBITDA margin, changes, pp
ОЗОН Фармацевтика (OZPH) EBITDA margin MSFO (quarter values) |
||||||||
| 2025Q2 | 2025Q3 | 2025Q4 | 2026Q1 | 2026Q2 | LTM ? | |||
| EBITDA margin, % | ? | 27.8% | 41.2% | 42.2% | 33.1% | 40.3% | 39.6% | |
| Changes by years, y/y, % | -5pp | +11pp | -8pp | -7pp | +13pp | |||
| Changes by quarters, q/q, % | -12pp | +13pp | +1pp | -9pp | +7pp | |||